SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (13077)9/19/2001 2:27:59 AM
From: rjm2  Read Replies (2) | Respond to of 78666
 
I took my first position in BEAV a few years ago at $13. (On the heels of some insider buying) it dropped to $6 and then did well. I sold out half at $19 and the other half at $24.75 on 2/2 & 3/7/01. So not long ago.

Plus the longterm chart shows it always rallies.

Some yahoos on the yahoo board are saying they will get all kind of business from making the cabin doors safer. While that may be true, there is no question the downturn will hurt. How much is the question. Conference call is tommorow.

My gut says it was panic selling and BEAV will have its day in the sun again. Of course, they are very leveraged so anything could happen.

Glad to see SPOR announced another buyback today. I think SPOR would have doubled if SPOR managers were in the WTC last week. I dont trust these guys any farther than I can throw them. But the stock is just DARN cheap.

I added some BONT at $2.01 yesterday for a small account I manage. Had a small order for myself at the same price that went unfilled.

I have to say overall I am disapointed in that a number of stocks I was hoping would fall did not. I was prepared with a few dozen limit orders at various prices on a bunch of stocks too.

I was sniffing around AINN but havent bought. Looking for insider favorites but just not finding a lot out there.

Would like to mention CRTQ again. I like this stock. Trades just above cash value with a whole bunch of biotech patents.
Insiders & 13-d buyer Biotech Value Partners continue to add to their positions. They are not burning cash either !